FACT SHEETS: Antibiotic Resistance Solutions Initiative
November 9, 2017
As part of the Antibiotic Resistance Solutions Initiative, CDC recently awarded $9 million to pilot innovative solutions and explore knowledge gaps about antibiotic resistance related to the human microbiome, healthcare settings, and surface water and soil. DSTDP’s funded project focuses on point-of-care antibiotic susceptibility testing for gonorrhea. CDC and investigators will develop and evaluate new molecular assays that can determine the antibiotics to which a patient’s strain of gonorrhea is susceptible. This fast and efficient test will help guide individual patient management and can be used to identify antibiotic-resistant strains of gonorrhea using molecular techniques rather than culture. It can also be used to support outbreak investigations of resistant gonorrhea in the community.
Click here to see the fact sheets.